Heat accelerates hydrolysis and oxidation well beyond the compound's expected stability window
Hypohomocysteinemia is medically defined as a homocysteine 15 mol/L in nonpregnant adults
Commonly Reported Side Effects Based on community reports, side effects appear relatively uncommon and typically mild: Most Frequently Reported: Injection site reactions (redness, minor pain, itching) Mild nausea (particularly with oral administration) Temporary dizziness Headache Fatigue Less Commonly Reported: Skin flushing Changes in appetite Temporary mood changes Vivid dreams Theoretical Concerns Growth Factor Effects: BPC-157's upregulation of growth factors raises theoretical concerns for: Cancer promotion in those with existing malignancies Acceleration of undiagnosed tumors Effects on benign growths (polyps, fibroids) No evidence directly supports these concerns, but caution is warranted given the mechanisms involved
About DSIP DSIP (Delta Sleep-Inducing Peptide) is a neuropeptide first isolated from cerebral venous blood of rabbits in 1974 by Marcel Monnier and colleagues at the University of Basel
The peptide functions as a precision senolytic agent by competing with endogenous FOXO4 for p53 binding, releasing the tumor suppressor protein to trigger apoptosis specifically in cells that have accumulated the senescence-associated secretory phenotype (SASP) markers
This can contribute to improved training capacity and delayed fatigue during physical activity